Log in
Enquire now
‌

US Patent 11643452 Fc-epsilon car

Patent 11643452 was granted and assigned to ImmunityBio on May, 2023 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Patent Applicant
0
Current Assignee
ImmunityBio
ImmunityBio
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
116434520
Patent Inventor Names
Laurent H. Boissel0
Abhijit Dandapat0
Hans G. Klingemann0
Himani Chinnapen0
Date of Patent
May 9, 2023
0
Patent Application Number
173410980
Date Filed
June 7, 2021
0
Patent Citations
‌
US Patent 11129850 Quadricistronic system comprising a homing receptor and chimeric antigen receptor for stable genetic modification of cellular immunotherapies
0
‌
US Patent 11058723 Quadricistronic system comprising a homing receptor and chimeric antigen receptor for stable genetic modification of cellular immunotherapies
0
‌
US Patent 10023648 Anti-TOSO chimeric antigen receptor and its use
0
‌
US Patent 10138462 Natural killer cell lines and methods of use
0
‌
US Patent 10174095 Nucleic acid encoding a humanized anti-BCMA chimeric antigen receptor
0
‌
US Patent 10765701 Elimination of CD19-positive lymphoid malignancies by CD19-CAR expressing NK cells
0
‌
US Patent 10960024 Quadricistronic system comprising a homing receptor and chimeric antigen receptor for stable genetic modification of cellular immunotherapies
0
Patent Primary Examiner
‌
Ilia I Ouspenski
0

Recombinant NK cells, and especially recombinant NK-92 cells express a chimeric antigen receptor (CAR) having an intracellular domain of FcεRIγ. Notably, CAR constructs with an intracellular domain of FcεRIγ had a substantially prolonged duration of expression and significantly extended cytotoxicity over time. The CAR may be expressed from RNA and DNA, preferably as a tricistronic construct that further encodes CD16 and a cytokine to confer autocrine growth support. Advantageously, such constructs also enable high levels of transfection and expression of the recombinant proteins and provide a convenient selection marker to facilitate rapid production of recombinant NK/NK-92 cells.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 11643452 Fc-epsilon car

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.